Barriers to implementation of isoniazid preventive therapy in HIV clinics: A qualitative study

AIDS

Volumn 24, Issue SUPPL. 5, 2010, Pages

  Lester, Rebecca ^a   Hamilton, Robin ^b   Charalambous, Salome ^b   Dwadwa, Thobeka ^b   Chandler, Clare ^a   Churchyard, Gavin J ^b   Grant, Alison D ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b AURUM INSTITUTE   (South Africa)

Author keywords

isoniazid; preventive; qualitative; South Africa; tuberculosis

Indexed keywords

ISONIAZID;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; DONOR; FEMALE; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MALE; MEDICAL INFORMATION; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; QUALITATIVE RESEARCH; SOUTH AFRICA; TUBERCULOSIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTITUBERCULAR AGENTS; DELIVERY OF HEALTH CARE; FEMALE; HIV INFECTIONS; HUMANS; INTERVIEWS AS TOPIC; ISONIAZID; MALE; MIDDLE AGED; QUALITATIVE RESEARCH; SOUTH AFRICA; TUBERCULOSIS;

EID: 78649264950     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/01.aids.0000391021.18284.12     Document Type: Article

References (11)

1. WHO. Policy statement on preventive therapy against tuberculosis in people living with HIV 1998. http://whqlibdoc.who.int/ hq/1998/WHO-TB-98.255. pdf. [Accessed 12 September 2010].
2. Woldehanna S, Volmink J. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev 2004:CD000171.
3. Grant AD, Charalambous S, Fielding KL, Jay KH, Corbett EL, Chaisson RE, et al. Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental recruitment study. JAMA 2005; 293:2719-2725.
4. WHO. Three I's meeting. Report of a Joint WHO HIV/AIDS and TB Department Meeting. http://who.int/hiv/pub/meetingreports/ WHO-3Is-meeting-report.pdf. [Accessed 12 September 2010].
5. Chandler CIR, Jones C, Boniface G, Juma K, Reyburn H, Whitty CJ. Guidelines and mindlines: why do clinical staff over-diagnose malaria in Tanzania? A qualitative study. Malar J 2008; 2:53.
6. Rowe KA, Makhubele B, Hargreaves JR, Porter JD, Hausler HP, Pronyk PM. Adherence to TB preventive therapy for HIV-positive patients in rural South Africa: implications for anti-retroviral delivery in resource poor settings? Int J Tuberc Lung Dis 2005; 9:263-269.
7. Grimshaw JM, Thomas RE, MacLennanG,FraserC, Ramsay CR, Vale L, et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess 2004; 8:1-72.
8. Greenhalgh T, Robert G, Macfarlane F, Bate P, Kyriakidou O. Diffusion of innovations in service organizations: systematic review and recommendations. Milbank Q 2004; 82:581-629.
9. LocockL,Dopson S,ChambersD, Gabbay J. Understanding the role of opinion leaders in improving clinical effectiveness. Soc Sci Med 2001; 53:745-757.
10. World Health Organisation 2009. Medicines use in primary care in developing and transitional countries. Fact Book summarizing results from studies reported between 1990 and 2006. WHO/EMP/MAR/2009.3.
11. Balcells ME, Thomas SL, Godfrey-Faussett P, Grant AD. Iso-niazid preventive therapy and risk for resistant tuberculosis. Emerg Infect Dis 2006; 12:744-751.